PT  - JOURNAL ARTICLE
AU  - Van den Berg, L H
AU  - Kerkhoff, H
AU  - Oey, P L
AU  - Franssen, H
AU  - Mollee, I
AU  - Vermeulen, M
AU  - Jennekens, F G
AU  - Wokke, J H
TI  - Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulins: a double blind, placebo controlled study.
AID  - 10.1136/jnnp.59.3.248
DP  - 1995 Sep 01
TA  - Journal of Neurology, Neurosurgery & Psychiatry
PG  - 248--252
VI  - 59
IP  - 3
4099  - http://jnnp.bmj.com/content/59/3/248.short
4100  - http://jnnp.bmj.com/content/59/3/248.full
SO  - J Neurol Neurosurg Psychiatry1995 Sep 01; 59
AB  - The effect of high dose intravenous immunoglobulin (IVIg) treatment was studied in six patients with multifocal motor neuropathy (MMN). All patients responded to treatment (0.4 g/kg for five consecutive days) in an open trial. The effect of IVIg treatment was confirmed for each patient in a single patient, double blind, placebo controlled trial. Four patients received two IVIg treatments and two placebo treatments, and two patients received one IVIg and one placebo treatment in a randomised order. Five out of six patients responded to IVIg but not to placebo. One patient responded to IVIg in the same manner as to placebo treatment. Thus IVIg treatment can lead to improvement of muscle strength in patients with MMN.